{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-256445","form_type":"8-K","ticker":"GUTS","cik":"0001572616","company_name":"FRACTYL HEALTH, INC.","filed_at":"2026-06-04T11:05:16+00:00","discovered_at":"2026-06-04T11:10:00.264127+00:00","generated_at":"2026-06-04T11:10:13.887928+00:00","sec_items":["7.01","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Fractyl Health reports positive 1-year REVEAL-1 data: ~78% weight maintenance post-GLP-1 with Revita.","bullets":["Participants retained ~78% of prior GLP-1-induced weight loss at one year after single Revita procedure.","33% of patients continued losing weight at one year; mean weight change 5.3% (n=15) vs ~15% regain with GLP-1 withdrawal alone.","No procedure-related serious adverse events; mild events occurred in 36% of participants, all transient.","Next data readouts: REMAIN-1 Midpoint Cohort randomized data Q3 2026, REMAIN-1 Pivotal Cohort topline Q4 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-256445","json":"https://secwatch.observer/filing/0001193125-26-256445.json","markdown":"https://secwatch.observer/filing/0001193125-26-256445.md","text":"https://secwatch.observer/filing/0001193125-26-256445.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1572616/000119312526256445/0001193125-26-256445-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1572616/000119312526256445/guts-20260604.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T11:10:13.887928+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}